Whole-body MR imaging in the German national cohort: Rationale, design, and technical background1

Radiology

Volumn 277, Issue 1, 2015, Pages 206-220

  Bamberg, Fabian ^a   Kauczor, Hans Ulrich ^a   Weckbach, Sabine ^a   Schlett, Christopher L ^a   Forsting, Michael ^a   Ladd, Susanne C ^a   Greiser, Karin Halina ^a   Weber, Marc André ^a   Schulz Menger, Jeanette ^a   Niendorf, Thoralf ^a   Pischon, Tobias ^a   Caspers, Svenja ^a   Amunts, Katrin ^a   Berger, Klaus ^a   Bülow, Robin ^a   Hosten, Norbert ^a   Hegenscheid, Katrin ^a   Kröncke, Thomas ^a   Linseisen, Jakob ^a   Günther, Matthias ^a   Hirsch, Jochen G ^a   Köhn, Alexander ^a   Hendel, Thomas ^a   Wichmann, Heinz Erich ^a   Schmidt, Börge ^a   Jöckel, Karl Heinz ^a   Hoffmann, Wolfgang ^a   Kaaks, Rudolf ^a   Reiser, Maximilian F ^a   Völzke, Henry ^a   more..

^a German National Cohort (GNC) Consortium Central Executive Office of the German National Cohort   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; GERMAN (CITIZEN); HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INCIDENCE; INCIDENTAL FINDING; MALE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TREATMENT DURATION; WATER CONTENT; WHOLE BODY MRI; CLINICAL TRIAL; GERMANY; METHODOLOGY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; STANDARDS; WHOLE BODY IMAGING;

GERMANY; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING; RESEARCH DESIGN; WHOLE BODY IMAGING;

EID: 84942421037     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015142272     Document Type: Article

References (57)

1. Völzke H, Schmidt CO, Hegenscheid K, et al. Population imaging as valuable tool for personalized medicine. Clin Pharmacol Ther 2012;92(4):422-424.
2. Rothman J, Greenland S. Modern epidemiology. Philadelphia, Pa: Lippincott-Raven, 1998.
3. Hofman A, van Duijn CM, Franco OH, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011;26(8): 657-686.
4. Splansky GL, Corey D, Yang Q, et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007; 165(11):1328-1335.
5. Bild DE, Bluemke DA, Burke GL, et al. Multiethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002;156(9): 871-881.
6. Schmermund A, Möhlenkamp S, Stang A, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study: risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 2002;144(2):212-218.
7. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011;40(2):294-307.
8. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129(4):687-702.
9. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronaryevents in four racial or ethnic groups. N Engl J Med 2008;358(13):1336-1345.
10. Erbel R, Möhlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010;56(17):1397-1406.
11. Chuang ML, Gona P, Salton CJ, et al. Usefulness of the left ventricular myocardial contraction fraction in healthy men and women to predict cardiovascular morbidity and mortality. Am J Cardiol 2012;109(10):1454-1458.
12. Kühn JP, Hernando D, Muñoz del Rio A, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265(1):133-142.
13. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 2006;113(5):657-663.
14. Schlemmer HP, Schäfer J, Pfannenberg C, et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 2005;40(2):64-71.
15. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003;290(24):3199-3206.
16. Zhu Y, Hardy CJ, Sodickson DK, et al. Highly parallel volumetric imaging with a 32-element RF coil array. Magn Reson Med 2004; 52(4):869-877.
17. Sodickson DK, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 1997;38(4):591-603.
18. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42(5): 952-962.
19. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47(6):1202-1210.
20. Kallmes DF, Hui FK, Mugler JP 3rd. Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a singleslab three-dimensional pulse sequence: initial experience. Radiology 2001;221(1):251-255.
21. Zenge MO, Ladd ME, Vogt FM, Brauck K, Barkhausen J, Quick HH. Whole-body magnetic resonance imaging featuring moving table continuous data acquisition with highprecision position feedback. Magn Reson Med 2005;54(3):707-711.
22. Goyen M, Quick HH, Debatin JF, et al. Wholebody three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 2002;224(1):270-277.
23. Gebker R, Gomaa O, Schnackenburg B, Rebakowski J, Fleck E, Nagel E. Comparison of different MRI techniques for the assessment of thoracic aortic pathology: 3D contrast enhanced MR angiography, turbo spin echo and balanced steady state free precession. Int J Cardiovasc Imaging 2007;23(6):747-756.
24. Glockner JF, Takahashi N, Kawashima A, et al. Non-contrast renal artery MRA using an inflow inversion recovery steady state free precession technique (Inhance): comparison with 3D contrast-enhanced MRA. J Magn Reson Imaging 2010;31(6):1411-1418.
25. German National Cohort (GNC) Consortium. The German National Cohort: aims, study design and organization. Eur J Epidemiol 2014;29(5):371-382.
26. Booth TC, Jackson A, Wardlaw JM, Taylor SA, Waldman AD. Incidental findings found in "healthy" volunteers during imaging performed for research: current legal and ethical implications. Br J Radiol 2010; 83(990):456-465.
27. Hoffmann M. Two basic ethical problems of incidental findings in population-based, nonintervening magnetic resonance imaging (MRI) research. J Eval Clin Pract 2013;19(3): 427-432.
28. Robinson-Cohen C, Hoofnagle AN, Ix JH, et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 2013;310(2):179-188.
29. Hoffmann W, Latza U, Terschüren C. Good Epidemiological Practice (GEP). http://ieaweb.org/good-epidemiological-practicegep/. Published 2008. Accessed December 12, 2014.
30. Gallo V, Egger M, McCormack V, et al. STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME-an extension of the STROBE statement. J Clin Epidemiol 2011;64(12):1350-1363.
31. Hutton C, Draganski B, Ashburner J, Weiskopf N. A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 2009; 48(2):371-380.
32. Singer J, Trollor JN, Baune BT, Sachdev PS, Smith E. Arterial stiffness, the brain and cognition: a systematic review. Ageing Res Rev 2014;15:16-27.
33. Gusnard DA, Raichle ME, Raichle ME. Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci 2001;2(10):685-694.
34. Hutchison RM, Womelsdorf T, Allen EA, et al. Dynamic functional connectivity: promise, issues, and interpretations. Neuroimage 2013;80:360-378.
35. Ferreira LK, Busatto GF. Resting-state functional connectivity in normal brain aging. Neurosci Biobehav Rev 2013;37(3):384-400.
36. Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV. Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiol Aging 2011; 32(10):1733-1741.
37. Sheline YI, Raichle ME. Resting state functional connectivity in preclinical Alzheimer's disease. Biol Psychiatry 2013;74(5):340-347.
38. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006; 48(7):1475-1497.
39. Thiele H, Nagel E, Paetsch I, et al. Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging 2001;14(4):362-367.
40. Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15(1):92.
41. Machann J, Thamer C, Schnoedt B, et al. Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 2005;21(4):455-462.
42. Krauss RM, Winston M, Fletcher BJ, Grundy SM. Obesity: impact on cardiovascular disease. Circulation 1998;98(14):1472-1476.
43. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348(17):1625-1638.
44. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116(1):39-48.
45. Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012;126(10):1301-1313.
46. Zhong X, Nickel MD, Kannengiesser SA, Dale BM, Kiefer B, Bashir MR. Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med 2014;72(5):1353-1365.
47. Tateishi S, Uchikochi M, Miyazaki S, et al. More accurate estimation in prostate volume achieved by optimized single slab 3D SPACE compared with 2D-TSE: a quantitative study based on the radical prostatectomy specimens [abstr]. In: Proceedings of the Twenty-Second Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2014; 3573.
48. Wang Z, Bovik AC. A universal image quality index. IEEE Signal Process Lett 2002; 9(3):81-84.
49. Wood ML, Henkelman RM. MR image artifacts from periodic motion. Med Phys 1985; 12(2):143-151.
50. The Royal College of Radiologists. Management of incidental findings detected during research imaging. London, England: The Royal College of Radiologists, 2011.
51. Hegenscheid K, Seipel R, Schmidt CO, et al. Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management. Eur Radiol 2013;23(3):816-826.
52. Lumbreras B, Donat L, Hernández-Aguado I. Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol 2010;83(988):276-289.
53. Hegenscheid K, Kühn JP, Völzke H, Biffar R, Hosten N, Puls R. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study. Rofo 2009;181(8):748-759.
54. Petersen SE, Matthews PM, Bamberg F, et al. Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank: rationale, challenges and approaches. J Cardiovasc Magn Reson 2013;15(1):46.
55. Schmidt G, Dinter D, Reiser MF, Schoenberg SO. The uses and limitations of wholebody magnetic resonance imaging. Dtsch Arztebl Int 2010;107(22):383-389.
56. Ladd SC. Whole-body MRI as a screening tool? Eur J Radiol 2009;70(3):452-462.
57. Chung H, McClelland RL, Katz R, Carr JJ, Budoff MJ. Repeatability limits for measurement of coronary artery calcified plaque with cardiac CT in the Multi-Ethnic Study of Atherosclerosis. AJR Am J Roentgenol 2008;190(2):W87-W92.